ATI RN
ATI Nurs 180 Pharmacology Exam Questions
Extract:
Question 1 of 5
A client with hypertension and benign prostate hyperplasia is prescribed doxazosin (Cardura). Which of the following statements below would the nurse emphasize regarding doxazosin (Cardura)?
Correct Answer: B
Rationale: Doxazosin's first-dose hypotension can cause dizziness, so lying down after the initial dose minimizes fall risk.
Question 2 of 5
A charge nurse is teaching a group of nurses about the antagonist action of reversal medications. For each medication listed below, click to specify the expected reversal agent.
| Options | Glucagon | Protamine sulfate | Vitamin K | Andexanet alfa |
|---|---|---|---|---|
| Warfarin: Vitamin K | ||||
| Heparin: Protamine sulfate | ||||
| Rivaroxaban: Andexanet alfa | ||||
| Beta Blockers: Glucagon |
Correct Answer: A,B,C,D
Rationale: Vitamin K reverses warfarin, protamine sulfate neutralizes heparin, andexanet alfa counters rivaroxaban, and glucagon mitigates beta-blocker overdose effects.
Question 3 of 5
A client presents to the healthcare setting and ordered verapamil (Calan) to treat his hypertension. Which assessment finding by the nurse would determine if the medication should be held?
Correct Answer: D
Rationale: Verapamil may be held if the pulse is significantly low (<60 bpm) due to its heart rate-lowering effect, though 78 bpm is normal.
Question 4 of 5
A nurse is teaching a client who has angina about nitroglycerin sublingual tablets. Which of the following statements should the nurse include in the teaching?
Correct Answer: D
Rationale: Nitroglycerin dilates blood vessels, increasing cardiac oxygen delivery to relieve angina, its primary therapeutic effect.
Question 5 of 5
The nurse is caring for a client following a myocardial infarction (MI) and prescribed aspirin 325mg PO daily. Which of following effects of this medication would this client benefit from following a MI?
Correct Answer: D
Rationale: Aspirin's platelet aggregation inhibition prevents further clot formation, reducing cardiovascular event risk post-MI.